CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Treatment Starling SV monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02837731
NCT02837731N/ACompleted

Evaluation of Fluid Volume in Patients With Sepsis and Refractory Hypotension

Cheetah Medical Inc.·interventional·Posted Jul 20, 2016·Updated Dec 3, 2020

In Brief

A clinical study evaluating Treatment Starling SV monitor for Sepsis and Hypotension. Completed, enrolled 150 participants across 12 sites in 2 countries.

Detailed Summary

This study assesses the mean difference in fluid balance at ICU discharge and associated patient outcomes, based on a dynamic assessment of fluid responsiveness in septic patients with refractory hypotension in an ICU setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Hypotension
CountriesUnited Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 20, 2016
Enrollment StartOct 1, 2016
Primary CompletionMar 1, 2019
Study CompletionMar 13, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.0 years ago

Interventions

Treatment Starling SV monitordevice

A dynamic assessment of fluid responsiveness will be performed at every clinical decision point for the first 72 hours of study enrollment. Fluid responsiveness will be assessed using a passive leg raise (PLR) and Starling SV hemodynamic monitor to guide corresponding treatment.